The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysis.
Journal Information
Full Title: Cancer Med
Abbreviation: Cancer Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST STATEMENT The authors have no conflict of interest."
Funding Disclosure
Evidence found in paper:
"FUNDING INFORMATION The study was supported partly by a grant from Chang Gung Memorial Hospital, Kaohsiung, Taiwan (CMRPG8M0651, CMRPG8K1661, CPRPG8J0012)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025